Nice little read for ZMTXer's
Profile: ZymeTx, Inc. is an emerging biotechnology company engaged in the development of unique diagnostic and therapeutic products for the management of viral diseases.
ZymeTx, Inc. is an emerging biotechnology company engaged in the development of unique products for the diagnosis and treatment of viral disease. Located in Oklahoma City, ZymeTx was established through the research support of the Oklahoma Medical Research Foundation, a leading non-profit biomedical research facility. Today, ZymeTx is a leader in the effort to provide new solutions for the management of infectious viruses. ZymeTx's proprietary ViraZyme® technology platform is based on targeting specific sites on viral enzymes. While many aspects of a virus mutate over time to evade antibody attack, these small sites are conserved. By developing compounds that interact with these very specific viral targets, ZymeTx is simultaneously developing both diagnostic and therapeutic products. The initial product to arise from this program, ZstatFlu™, is the world's first point-of-care influenza test that can reliably and quickly diagnose all strains of influenza A and B. The Company is also developing a number of influenza therapeutics, three of which are now in pre-clinical testing. Today, viral diseases represent one of the most compelling and exciting opportunities for medical progress. ZymeTx is committed to utilizing unique technology platforms and techniques to introduce the next generation of products for viral disease management.
AI
